The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention

MLA

Zhaowei Zhang, et al. “The Impact of Cytochrome 450 and Paraoxonase Polymorphisms on Clopidogrel Resistance and Major Adverse Cardiac Events in Coronary Heart Disease Patients after Percutaneous Coronary Intervention.” BMC Pharmacology and Toxicology, vol. 21, no. 1, Jan. 2020, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s40360-019-0378-7.

APA

Zhaowei Zhang, Mingxiao Chen, Long Zhang, & Qiang Zhao. (2020). The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention. BMC Pharmacology and Toxicology, 21(1), 1–9. https://doi.org/10.1186/s40360-019-0378-7

Chicago

Zhaowei Zhang, Mingxiao Chen, Long Zhang, and Qiang Zhao. 2020. “The Impact of Cytochrome 450 and Paraoxonase Polymorphisms on Clopidogrel Resistance and Major Adverse Cardiac Events in Coronary Heart Disease Patients after Percutaneous Coronary Intervention.” BMC Pharmacology and Toxicology 21 (1): 1–9. doi:10.1186/s40360-019-0378-7.